The rapidly advancing field of biodefense benefits many other, critical public health concerns.
Identifieur interne : 004583 ( Main/Exploration ); précédent : 004582; suivant : 004584The rapidly advancing field of biodefense benefits many other, critical public health concerns.
Auteurs : James C. Burnett [États-Unis] ; Rekha G. Panchal ; M Javad Aman ; Sina BavariSource :
- Discovery medicine [ 1944-7930 ] ; 2005.
Abstract
Extract: In 2001, the public was introduced to one of the deadliest of biowarfare agents -- Bacillus anthracis -- the bacterium that causes anthrax. At the time, it was unimaginable that one might come into contact with such a deadly pathogen by simply opening the mail. Today anthrax is a nearly ubiquitous household word. This single act of bioterrorism had a profound effect in that it clearly demonstrated that even a small-scale attack could incur huge repercussions: the loss of life, the need for thousands to be treated with prophylaxis, public panic, and a large economic toll. Following this realization, a major government effort to find new and more effective ways to detect, diagnose, and therapeutically counter biothreat agents was initiated. So, how has this initiative fared?
PubMed: 20704875
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002614
- to stream PubMed, to step Curation: 002614
- to stream PubMed, to step Checkpoint: 002420
- to stream Ncbi, to step Merge: 002189
- to stream Ncbi, to step Curation: 002189
- to stream Ncbi, to step Checkpoint: 002189
- to stream Main, to step Merge: 004822
- to stream Main, to step Curation: 004583
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The rapidly advancing field of biodefense benefits many other, critical public health concerns.</title><author><name sortKey="Burnett, James C" sort="Burnett, James C" uniqKey="Burnett J" first="James C" last="Burnett">James C. Burnett</name><affiliation wicri:level="2"><nlm:affiliation>Target Structure-Based Drug Discovery Group, Developmental Therapeutics Program, National Cancer Institute, Frederick, MD 21702, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Target Structure-Based Drug Discovery Group, Developmental Therapeutics Program, National Cancer Institute, Frederick, MD 21702</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Panchal, Rekha G" sort="Panchal, Rekha G" uniqKey="Panchal R" first="Rekha G" last="Panchal">Rekha G. Panchal</name></author><author><name sortKey="Aman, M Javad" sort="Aman, M Javad" uniqKey="Aman M" first="M Javad" last="Aman">M Javad Aman</name></author><author><name sortKey="Bavari, Sina" sort="Bavari, Sina" uniqKey="Bavari S" first="Sina" last="Bavari">Sina Bavari</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2005">2005</date><idno type="RBID">pubmed:20704875</idno><idno type="pmid">20704875</idno><idno type="wicri:Area/PubMed/Corpus">002614</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002614</idno><idno type="wicri:Area/PubMed/Curation">002614</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002614</idno><idno type="wicri:Area/PubMed/Checkpoint">002420</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002420</idno><idno type="wicri:Area/Ncbi/Merge">002189</idno><idno type="wicri:Area/Ncbi/Curation">002189</idno><idno type="wicri:Area/Ncbi/Checkpoint">002189</idno><idno type="wicri:Area/Main/Merge">004822</idno><idno type="wicri:Area/Main/Curation">004583</idno><idno type="wicri:Area/Main/Exploration">004583</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The rapidly advancing field of biodefense benefits many other, critical public health concerns.</title><author><name sortKey="Burnett, James C" sort="Burnett, James C" uniqKey="Burnett J" first="James C" last="Burnett">James C. Burnett</name><affiliation wicri:level="2"><nlm:affiliation>Target Structure-Based Drug Discovery Group, Developmental Therapeutics Program, National Cancer Institute, Frederick, MD 21702, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Target Structure-Based Drug Discovery Group, Developmental Therapeutics Program, National Cancer Institute, Frederick, MD 21702</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Panchal, Rekha G" sort="Panchal, Rekha G" uniqKey="Panchal R" first="Rekha G" last="Panchal">Rekha G. Panchal</name></author><author><name sortKey="Aman, M Javad" sort="Aman, M Javad" uniqKey="Aman M" first="M Javad" last="Aman">M Javad Aman</name></author><author><name sortKey="Bavari, Sina" sort="Bavari, Sina" uniqKey="Bavari S" first="Sina" last="Bavari">Sina Bavari</name></author></analytic><series><title level="j">Discovery medicine</title><idno type="eISSN">1944-7930</idno><imprint><date when="2005" type="published">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Extract: In 2001, the public was introduced to one of the deadliest of biowarfare agents -- Bacillus anthracis -- the bacterium that causes anthrax. At the time, it was unimaginable that one might come into contact with such a deadly pathogen by simply opening the mail. Today anthrax is a nearly ubiquitous household word. This single act of bioterrorism had a profound effect in that it clearly demonstrated that even a small-scale attack could incur huge repercussions: the loss of life, the need for thousands to be treated with prophylaxis, public panic, and a large economic toll. Following this realization, a major government effort to find new and more effective ways to detect, diagnose, and therapeutically counter biothreat agents was initiated. So, how has this initiative fared?</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Maryland</li></region></list><tree><noCountry><name sortKey="Aman, M Javad" sort="Aman, M Javad" uniqKey="Aman M" first="M Javad" last="Aman">M Javad Aman</name><name sortKey="Bavari, Sina" sort="Bavari, Sina" uniqKey="Bavari S" first="Sina" last="Bavari">Sina Bavari</name><name sortKey="Panchal, Rekha G" sort="Panchal, Rekha G" uniqKey="Panchal R" first="Rekha G" last="Panchal">Rekha G. Panchal</name></noCountry><country name="États-Unis"><region name="Maryland"><name sortKey="Burnett, James C" sort="Burnett, James C" uniqKey="Burnett J" first="James C" last="Burnett">James C. Burnett</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004583 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004583 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:20704875
|texte= The rapidly advancing field of biodefense benefits many other, critical public health concerns.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:20704875" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |